Castleark Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Castleark Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$25.16 - $41.38 $2.16 Million - $3.55 Million	85,690 New	85,690 $3.06 Million
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $3.01 Million - $5.32 Million	-76,020 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$58.09 - $82.51 $119,665 - $169,970	2,060 Added 2.79%	76,020 $5.04 Million
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $218,341 - $317,750	-3,740 Reduced 4.81%	73,960 $4.62 Million
Q2 2021 Aug 17, 2021	BUY	$62.15 - $90.32 $654,750 - $951,521	10,535 Added 15.69%	77,700 $6.44 Million
Q1 2021 May 14, 2021	BUY	$61.35 - $90.47 $102,761 - $151,537	1,675 Added 2.56%	67,165 $4.45 Million
Q4 2020 Feb 17, 2021	SELL	$43.82 - $85.37 $623,996 - $1.22 Million	-14,240 Reduced 17.86%	65,490 $5.03 Million
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $2.65 Million - $4.09 Million	79,730 New	79,730 $3.43 Million

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.